Should all pregnant diabetic women undergo a fetal echocardiography? A cost-effectiveness analysis comparing four screening strategies

Prenatal Diagnosis

Volumn 26, Issue 1, 2006, Pages 39-44

  Odibo, Anthony O ^a,b   Coassolo, Kara M ^a   Stamilio, David M ^a   Ural, Serdar H ^a   Macones, George A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac anomalies; Diabetes; Fetal echocardiogram

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; CONGENITAL HEART DISEASE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FEMALE; FETUS; FETUS DEATH; FETUS ECHOGRAPHY; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ECHOCARDIOGRAPHY; FEMALE; HEART DEFECTS, CONGENITAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PENNSYLVANIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY IN DIABETICS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 31944450214     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1322     Document Type: Article

References (28)

1. Albert TJ, Landon MB, Wheller JJ, Samuels P, Cheng RF, Gabbe S. 1996. Prenatal detection of fetal anomalies in pregnancies complicated by insulin-dependent diabetes mellitus. Am J Obstet Gynecol 174: 1424-1428.
2. Allan LD, Sharland GK, Milburn A, et al. 1994. Prospective diagnosis of 1006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 23: 1452-1458.
3. Bromley B, Estroff JA, Sanders SP, et al. 1992. Fetal echocardiography: accuracy and limitations in a population at high and low-risk for heart defects. Am J Obstet Gynecol 166: 1473-1481.
4. Chang AC, Huhta JC, Yoon GY, et al. 1991. Diagnosis, transport, and outcome in fetuses with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg 102: 841-848. s
5. Chaoui R. 2003. The four-chamber view: four reasons why it seems to fail in screening for cardiac abnormalities and suggestions to improve detection rates. Ultrasound Obstet Gynecol 22: 3-10
6. . Copel JA, Pilu G, Kleinman CS. 1986. Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography. Am J Obstet Gynecol 154: 1121-1132.
7. Copel JA, Tan ASA, Kleinman CS. 1997. Does prenatal diagnosis of congenital heart disease alter short-term outcome? Ultrasound Obstet Gynecol 10: 237-241.
8. Drummond M, McGuire A. 2001. Economic Evaluation in Health Care: Merging Theory with Practice (1st edn). Oxford University Press: Oxford.
9. Eisenberg JM. 1989. Clinical economics: a guide to the economic analysis of clinical practices. JAMA 20: 2879-2886.
10. Finkler SA. 1982. The distinction between cost and charges. Ann Intern Med 96: 102-109.
11. Furlong WJ, Feeny DH, Torrance GW, Barr RD. 2001. The Health Utilities Index (HUI) systems for assessing health-related quality of life in clinical studies. Ann Med 33: 375-384.
12. Gomez KJ, Dowdy K, Allen G, Tyson-Thomas M, Cruz AC. 1988. Evaluation of ultrasound diagnosis of fetal anomalies in women with pregestational diabetes: University of Florida experience. Am J Obstet Gynecol 159: 584-586.
13. Medicare. 1995. US Department of Health and Human Services. National Limitations-Clinical Lab: Washington, DC.
14. Meyer-Wittkopf M, Simpson JM, Sharland GK. 1996. Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases. Ultrasound Obstet Gynecol 8: 8-10.
15. Miller E, Hare JW, Clotherty JP, et al. 1981. Elevated maternal hemoglobin A1C in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304: 1331-1334.
16. Ott WJ. 1995. The accuracy of antenatal fetal echocardiography screening in high- and low-risk patients. Am J Obstet Gynecol 172: 1741-1749.
17. Perolo A, Prandstraller D, Ghi T, et al. 2001. Diagnosis and management of fetal cardiac anomalies: 10 years of experience at a single institution. Ultrasound Obstet Gynecol 18: 615-618.
18. Rowland TW, Hubbell JP, Nadas AS. 1973. Congenital heart disease in infants of diabetic mothers. J Pediatr 83: 815-820.
19. Shields LE, Gan EA, Murphy HF, Sahn DJ, Moore TR. 1993. The prognostic value of hemoglobin A1c in predicting fetal heart disease in diabetic pregnancies. Obstet Gynecol 81: 954-957.
20. Smith RS, Comstock CH, Lorenz RP, Kirk JS, Lee W. 1997. Maternal diabetes mellitus: which views are essential for fetal echocardiography? Obstet Gynecol 90: 575-579.
21. Smythe JF, Copel JA, Kleinman CS. 1992. Outcome of prenatally detected cardiac malformations. Am J Cardiol 69: 1471-1474.
22. Stubbs SM, Doddridge MC, John PN, Steel JM, Wright AD. 1987. Haemoglobin A1 and congenital malformation. Diabet Med 4: 156-159.
23. Stumpflen I, Stumpflen A, Wimmer M, Bernaschek G. 1996. Effect of detailed echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 348: 854-857.
24. Tengs TO, Wallace MA. 2000. One thousand health-related quality-of-life outcomes. Med Care 38: 583-637.
25. Torrance GW. 1987. Utility approach to measuring health-related quality of life. J Chronic Dis 40: 593-600.
26. Vandenbussche FPHA, De Jong-Potjer LC, Stiggelbout AM, Le Cessie S, Keirse MJNC. 1999. Differences in the valuation of birth outcomes among pregnant women, mothers and obstetricians. Birth 26: 178-183.
27. Waitzman NJ, Romano PS, Scheffler RM. 1994. Estimates of the economic costs of birth defects. Inquiry 31: 188-205.
28. Waitzman NJ, Romano PS, Scheffler RM, Harris JA. 1995. Economic costs of birth defects and cerebral palsy-United States. 1992 morbidity and mortality. MMWR Morb Mortal Wkly Rep 44: 694-699.